Pretreatment Anti-Thyroid Autoantibodies Indicate Increased Risk for Thyroid Autoimmunity Secondary to Alemtuzumab: A Prospective Cohort Study

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2019.07.062

Related search